Earnings summaries and quarterly performance for NVIDIA.
Executive leadership at NVIDIA.
Jen-Hsun Huang
President and Chief Executive Officer
Ajay K. Puri
Executive Vice President, Worldwide Field Operations
Colette M. Kress
Executive Vice President and Chief Financial Officer
Debora Shoquist
Executive Vice President, Operations
Timothy S. Teter
Executive Vice President, General Counsel and Secretary
Board of directors at NVIDIA.
A. Brooke Seawell
Director
Aarti Shah
Director
Dawn Hudson
Director
Harvey C. Jones
Director
John O. Dabiri
Director
Mark A. Stevens
Director
Melissa B. Lora
Director
Persis S. Drell
Director
Robert K. Burgess
Director
Stephen C. Neal
Lead Independent Director
Tench Coxe
Director
Research analysts who have asked questions during NVIDIA earnings calls.
Joseph Moore
Morgan Stanley
7 questions for NVDA
Timothy Arcuri
UBS
7 questions for NVDA
Aaron Rakers
Wells Fargo
6 questions for NVDA
Vivek Arya
Bank of America Corporation
6 questions for NVDA
Ben Reitzes
Melius Research LLC
4 questions for NVDA
CJ Muse
Cantor Fitzgerald
4 questions for NVDA
Stacy Rasgon
Bernstein Research
4 questions for NVDA
Benjamin Reitzes
Melius Research
3 questions for NVDA
Christopher Muse
Cantor Fitzgerald
3 questions for NVDA
Jim Schneider
Goldman Sachs
3 questions for NVDA
Atif Malik
Citigroup Inc.
2 questions for NVDA
Toshiya Hari
Goldman Sachs Group, Inc.
2 questions for NVDA
Harlan Sur
JPMorgan Chase & Co.
1 question for NVDA
Jake Wilhelm
Wells Fargo Securities, LLC
1 question for NVDA
Mark Lipacis
Evercore ISI
1 question for NVDA
Matthew Ramsay
TD Cowen
1 question for NVDA
Pierre Ferragu
New Street Research
1 question for NVDA
Stacey Raskin
Bernstein Research
1 question for NVDA
Vivek Aria
Bank of America Securities
1 question for NVDA
Recent press releases and 8-K filings for NVDA.
- NVIDIA positions agentic AI as a “once in a generation” shift in healthcare, driving open innovation with 650+ language models and 250 datasets contributed to Hugging Face, and foundational systems like Nemotron, Clara, and Cosmos for reasoning, simulation, and physical AI.
- Enterprise adoption is accelerating: partners such as Abridge and Corti have deployed agentic systems in 200+ health systems, recapturing 30%+ of physicians’ administrative time to boost patient throughput and experience.
- NVIDIA is expanding lab automation through a Thermo Fisher collaboration on the DGX Spark benchtop AI supercomputer for real-time instrument quality-control agents, and with Multiply Labs and Opentrons to scale robotic workflows—cutting cell-therapy manufacturing costs by 70%.
- The company launched a $1 billion, five-year co-innovation AI lab with Eli Lilly in South San Francisco to co-locate AI researchers and drug-discovery scientists, aiming to flip the R&D paradigm toward computation-intensive discovery and manufacturing.
- Nvidia highlighted its 17th year in healthcare and described Agentic AI—models that reason, use tools, and retrieve trusted data—as being deployed in healthcare faster than any other industry.
- Announced a partnership with Thermo Fisher to integrate its IGX benchtop supercomputer into lab instruments for real-time autonomous quality control, and a $1 billion co-innovation AI lab with Eli Lilly to accelerate drug discovery, clinical development, and manufacturing over five years.
- Emphasized its open ecosystem—650 language models and 250 datasets on Hugging Face—alongside domain-specific models such as Nemotron Gen3, Clara biomedical AI, and the expanded BioNeMo biology platform to drive physical and biomedical AI.
- Showcased the rise of AI scientists—agentic systems that can design and analyze experiments digitally and execute them via robotics—targeting a transformation of the $300 billion pharma R&D market.
- Nvidia highlights agentic AI adoption in healthcare to alleviate clinician shortages and automate clerical tasks, improving efficiency and patient throughput.
- Company underscores its open-source AI ecosystem, contributing over 650 language models and 250 datasets on Hugging Face, with an end-to-end open models, data and tools strategy.
- Announced collaboration with Thermo Fisher to integrate IGX benchtop AI supercomputers and AI agents for autonomous lab operations and real-time quality control.
- Unveiled a $1 billion, 5-year co-innovation AI lab with Eli Lilly to develop integrated digital and physical AI infrastructure for accelerated drug discovery.
- Partnerschaft zur Entwicklung von Frontier-Modellen für biologische künstliche Superintelligenz unter Nutzung von NVIDIAs Nemotron-Familie und NeMo-Framework.
- Kombination von Owkins proprietären multimodalen Patientendaten mit NVIDIAs beschleunigter KI-Infrastruktur zur Steigerung von OwkinZero in Bezug auf Leistung, Skalierbarkeit und Sicherheit.
- Ziel ist es, durch agentenbasierte biologische Schlussfolgerungskapazitäten in Owkin K die Wirkstoffforschung und -entwicklung in der Biopharmaindustrie zu beschleunigen.
- NVIDIA teams with Speechmatics and Sully.ai to deliver next-generation autonomous healthcare agents and scribes built on NVIDIA AI infrastructure.
- Early deployments report 21× ROI, 2.4+ hours saved per physician per day, and 30 million minutes added back to the workforce.
- Speechmatics’ medical speech model achieves 93% real-time accuracy and 96% medical keyword recall, outperforming the nearest competitor by reducing keyword error rates by 50%.
- Accelsius closed a $65 million Series B round led by Johnson Controls, with strategic investment from Legrand.
- The funding will expand Accelsius’s Austin production facility and accelerate global deployment of two-phase, direct-to-chip liquid cooling solutions for AI data centers.
- Its NeuCool® platform delivers 35% OpEx savings over single-phase cooling and 8–17% total cost of ownership savings, addressing thermal demands of high-density GPU racks.
- Accelsius, part of NVIDIA’s Inception program, has secured a 300 MW campus deployment for DarkNX in Ontario, demonstrating early customer adoption.
- NVIDIA and Eli Lilly will invest up to $1 billion over five years to establish an AI co-innovation lab in the San Francisco Bay Area.
- The lab will combine Lilly’s drug discovery expertise with NVIDIA’s AI compute and infrastructure, leveraging the BioNeMo platform and Vera Rubin architecture to accelerate medicine development.
- The initiative aims to build a continuous learning system that links Lilly’s wet labs with computational dry labs for 24/7 AI-assisted experimentation.
- Beyond drug discovery, the collaboration will explore AI applications in manufacturing, medical imaging and supply chain optimization using NVIDIA Omniverse, robotics and digital twins.
- Lab operations are expected to begin early 2026 in South San Francisco.
- At CES, Nvidia CEO Jensen Huang introduced Alpamayo, an open-model family with chips, simulation tools and developer toolkits aimed at accelerating Level 4 autonomous driving for automakers.
- Alpamayo is currently at “advanced Level 2” requiring human supervision; Nvidia plans for the Mercedes CLA EV to ship its full self-driving stack including Alpamayo in Q1.
- Nvidia released a suite of open models (e.g., Nemotron, Cosmos, Isaac GR00T) across language, robotics and biomedical research, positioning its stack as the foundation for physical AI.
- Expanded its partnership with DDN on an AI factory architecture combining Rubin GPUs and DDN storage to improve data efficiency and GPU utilization in large AI deployments.
- NVIDIA and Lenovo unveiled the Lenovo AI Cloud Gigafactory under the Gigawatt AI Factory program at CES 2026, aiming to accelerate hybrid AI deployment across personal, enterprise and public platforms.
- The program enables AI-cloud providers to achieve time-to-first-token (TTFT) in weeks by delivering turnkey, liquid-cooled infrastructure, expert consulting and industrialized build processes.
- Initial offerings include the GB300 NVL72 rack-scale system with 72 NVIDIA Blackwell Ultra GPUs and 36 Grace CPUs, plus support for the upcoming Vera Rubin NVL72 AI supercomputer for training and inference.
- Lenovo provides end-to-end co-engineering, manufacturing, integration and lifecycle services—leveraging its Neptune liquid-cooling technology—to deploy large-scale, customized AI factories rapidly.
- At CES 2026, NVIDIA and Lenovo unveiled the Lenovo AI Cloud Gigafactory program to deploy gigawatt-scale AI factories, reducing time to first token for enterprise AI to just weeks.
- The initiative combines Lenovo’s Neptune liquid cooling technology with NVIDIA accelerated computing platforms—featuring 72-GPU Blackwell Ultra and 36-CPU Grace in a rack-scale system—to support next-gen AI workloads.
- It also supports the upcoming NVIDIA Vera Rubin NVL72 supercomputer for AI training and inference, integrating Rubin GPUs, Vera CPUs, SuperNICs ConnectX-9, BlueField-4 DPUs, and advanced Spectrum-X and Photonics networking.
- Lenovo’s end-to-end offering adds global manufacturing, integration and Hybrid AI Factory services, streamlining deployment and monetization of scalable AI infrastructure.
Fintool News
In-depth analysis and coverage of NVIDIA.

NVIDIA and Eli Lilly Commit $1 Billion to Build First-of-Its-Kind AI Drug Discovery Lab

Nvidia Hires First-Ever CMO, Poaching Google Cloud's Marketing Chief

xAI Burned $7.8 Billion in Nine Months on Just $107 Million Revenue

Nvidia Demands 100% Upfront Payment for H200 Chips to China—No Refunds, No Cancellations

xAI Closes $20 Billion Series E—the Largest AI Funding Round Ever—With Nvidia as Strategic Backer

xAI Raises $20 Billion as Nvidia and Cisco Bet on Elon Musk's AI Challenger
Quarterly earnings call transcripts for NVIDIA.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more